Please use this identifier to cite or link to this item: http://hdl.handle.net/10316/27701
Title: Galactodendritic Phthalocyanine Targets Carbohydrate- Binding Proteins Enhancing Photodynamic Therapy
Authors: Pereira, Patrícia M. R. 
Silva, Sandrina 
Cavaleiro, José A. S. 
Ribeiro, Carlos A. F. 
Tomé, João P. C. 
Fernandes, Rosa 
Issue Date: 24-Apr-2014
Publisher: PLOS
Citation: PEREIRA, Patricía M. R. [et. al] - Galactodendritic Phthalocyanine Targets Carbohydrate-Binding Proteins Enhancing Photodynamic Therapy. "PLOS one". ISSN 1932-6203. Vol. 9 Nº. 4 (2014) p. e95529
Serial title, monograph or event: PLOS one
Volume: 9
Issue: 4
Abstract: Photosensitizers (PSs) are of crucial importance in the effectiveness of photodynamic therapy (PDT) for cancer. Due to their high reactive oxygen species production and strong absorption in the wavelength range between 650 and 850 nm, where tissue light penetration is rather high, phthalocyanines (Pcs) have been studied as PSs of excellence. In this work, we report the evaluation of a phthalocyanine surrounded by a carbohydrate shell of sixteen galactose units distributed in a dendritic manner (PcGal16) as a new and efficient third generation PSs for PDT against two bladder cancer cell lines, HT-1376 and UMUC- 3. Here, we define the role of galacto-dendritic units in promoting the uptake of a Pc through interaction with GLUT1 and galectin-1. The photoactivation of PcGal16 induces cell death by generating oxidative stress. Although PDT with PcGal16 induces an increase on the activity of antioxidant enzymes immediately after PDT, bladder cancer cells are unable to recover from the PDT-induced damage effects for at least 72 h after treatment. PcGal16 co-localization with galectin-1 and GLUT1 and/or generation of oxidative stress after PcGal16 photoactivation induces changes in the levels of these proteins. Knockdown of galectin-1 and GLUT1, via small interfering RNA (siRNA), in bladder cancer cells decreases intracellular uptake and phototoxicity of PcGal16. The results reported herein show PcGal16 as a promising therapeutic agent for the treatment of bladder cancer, which is the fifth most common type of cancer with the highest rate of recurrence of any cancer.
URI: http://hdl.handle.net/10316/27701
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0095529
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
I&D IBILI - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
Galactodendritic Phthalocyanine.pdf5.96 MBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

38
checked on Jun 25, 2019

WEB OF SCIENCETM
Citations

32
checked on Jun 25, 2019

Page view(s) 1

2,881
checked on Sep 18, 2019

Download(s) 50

397
checked on Sep 18, 2019

Google ScholarTM

Check

Altmetric

Dimensions


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.